{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:05:13Z","timestamp":1765609513568},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"49","license":[{"start":{"date-parts":[[2012,2,20]],"date-time":"2012-02-20T00:00:00Z","timestamp":1329696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,2,20]],"date-time":"2012-02-20T00:00:00Z","timestamp":1329696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2012,12,6]]},"DOI":"10.1038\/onc.2012.10","type":"journal-article","created":{"date-parts":[[2012,2,20]],"date-time":"2012-02-20T14:10:43Z","timestamp":1329747043000},"page":"5090-5098","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["PIKE mediates EGFR proliferative signaling in squamous cell carcinoma cells"],"prefix":"10.1038","volume":"31","author":[{"given":"Z","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E-Y","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S D","family":"Pennypacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S M","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,20]]},"reference":[{"key":"BFonc201210_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF02893450","volume":"12","author":"Y Hiraishi","year":"2006","unstructured":"Hiraishi Y, Wada T, Nakatani K, Negoro K, Fujita S . Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas. Pathol Oncol Res 2006; 12: 87\u201391.","journal-title":"Pathol Oncol Res"},{"key":"BFonc201210_CR2","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/ijc.21454","volume":"118","author":"M Hanawa","year":"2006","unstructured":"Hanawa M, Suzuki S, Dobashi Y, Yamane T, Kono K, Enomoto N et al. EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus. Int J Cancer 2006; 118: 1173\u20131180.","journal-title":"Int J Cancer"},{"key":"BFonc201210_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1365-2559.2008.03159.x","volume":"53","author":"T Ettl","year":"2008","unstructured":"Ettl T, Schwarz S, Kleinsasser N, Hartmann A, Reichert TE, Driemel O . Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Histopathology 2008; 53: 567\u2013577.","journal-title":"Histopathology"},{"key":"BFonc201210_CR4","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1365-2559.2008.03021.x","volume":"52","author":"MA Kim","year":"2008","unstructured":"Kim MA, Lee HS, Lee HE, Jeon YK, Yang HK, Kim WH . EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number. Histopathology 2008; 52: 738\u2013746.","journal-title":"Histopathology"},{"key":"BFonc201210_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.lungcan.2005.10.016","volume":"51","author":"A Destro","year":"2006","unstructured":"Destro A, Ceresoli GL, Falleni M, Zucali PA, Morenghi E, Bianchi P et al. EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations. Lung Cancer 2006; 51: 207\u2013215.","journal-title":"Lung Cancer"},{"key":"BFonc201210_CR6","doi-asserted-by":"publisher","first-page":"8594","DOI":"10.1158\/1078-0432.CCR-04-0690","volume":"10","author":"BA Schiff","year":"2004","unstructured":"Schiff BA, McMurphy AB, Jasser SA, Younes MN, Doan D, Yigitbasi OG et al. Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer. Clin Cancer Res 2004; 10: 8594\u20138602.","journal-title":"Clin Cancer Res"},{"key":"BFonc201210_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ygyno.2005.07.124","volume":"100","author":"CA Livasy","year":"2006","unstructured":"Livasy CA, Reading FC, Moore DT, Boggess JF, Lininger RA . EGFR expression and HER2\/neu overexpression\/amplification in endometrial carcinosarcoma. Gynecol Oncol 2006; 100: 101\u2013106.","journal-title":"Gynecol Oncol"},{"key":"BFonc201210_CR8","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/ijc.22928","volume":"121","author":"Z Rakosy","year":"2007","unstructured":"Rakosy Z, Vizkeleti L, Ecsedi S, Voko Z, Begany A, Barok M et al. EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis. Int J Cancer 2007; 121: 1729\u20131737.","journal-title":"Int J Cancer"},{"key":"BFonc201210_CR9","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1007\/s00268-007-9016-4","volume":"31","author":"G Galizia","year":"2007","unstructured":"Galizia G, Lieto E, Orditura M, Castellano P, Mura AL, Imperatore V et al. Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery. World J Surg 2007; 31: 1458\u20131468.","journal-title":"World J Surg"},{"key":"BFonc201210_CR10","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/sj.bjc.6603619","volume":"96","author":"I Zlobec","year":"2007","unstructured":"Zlobec I, Vuong T, Hayashi S, Haegert D, Tornillo L, Terracciano L et al. A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy. Br J Cancer 2007; 96: 793\u2013800.","journal-title":"Br J Cancer"},{"key":"BFonc201210_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/annonc\/mdi006","volume":"16","author":"JP Spano","year":"2005","unstructured":"Spano JP, Lagorce C, Atlan D, Milano G, Domont J, Benamouzig R et al. Impact of EGFR expression on colorectal cancer patient prognosis and survival. Ann Oncol 2005; 16: 102\u2013108.","journal-title":"Ann Oncol"},{"key":"BFonc201210_CR12","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1159\/000279388","volume":"77","author":"G Lurje","year":"2009","unstructured":"Lurje G, Lenz HJ . EGFR signaling and drug discovery. Oncology 2009; 77: 400\u2013410.","journal-title":"Oncology"},{"key":"BFonc201210_CR13","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0959-8049(03)00235-1","volume":"39","author":"F Ciardiello","year":"2003","unstructured":"Ciardiello F, Tortora G . Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs. Eur J Cancer 2003; 39: 1348\u20131354.","journal-title":"Eur J Cancer"},{"key":"BFonc201210_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.coph.2005.02.007","volume":"5","author":"G Speake","year":"2005","unstructured":"Speake G, Holloway B, Costello G . Recent developments related to the EGFR as a target for cancer chemotherapy. Curr Opin Pharmacol 2005; 5: 343\u2013349.","journal-title":"Curr Opin Pharmacol"},{"key":"BFonc201210_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0014-4827(02)00105-2","volume":"284","author":"RC Harris","year":"2003","unstructured":"Harris RC, Chuang E, Coffey RJ . EGF receptor ligands. Exp Cell Res 2003; 284: 2\u201313.","journal-title":"Exp Cell Res"},{"key":"BFonc201210_CR16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1357-2725(99)00015-1","volume":"31","author":"A Wells","year":"1999","unstructured":"Wells A . EGF receptor. Int J Biochem Cell Biol 1999; 31: 637\u2013643.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFonc201210_CR17","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1016\/S0021-9258(19)50143-0","volume":"267","author":"D Rotin","year":"1992","unstructured":"Rotin D, Honegger AM, Margolis BL, Ullrich A, Schlessinger J . Presence of SH2 domains of phospholipase C-\u03b31 enhances substrate phosphorylation by increasing the affinity toward the epidermal growth factor receptor. J Biol Chem 1992; 267: 9678\u20139683.","journal-title":"J Biol Chem"},{"key":"BFonc201210_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/emm.2000.18","volume":"32","author":"MJ Kim","year":"2000","unstructured":"Kim MJ, Kim E, Ryu SH, Suh PG . The mechanism of phospholipase C-\u03b31 regulation. Exp Mol Med 2000; 32: 101\u2013109.","journal-title":"Exp Mol Med"},{"key":"BFonc201210_CR19","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/emboj\/17.2.414","volume":"17","author":"M Falasca","year":"1998","unstructured":"Falasca M, Logan SK, Lehto VP, Baccante G, Lemmon MA, Schlessinger J . Activation of phospholipase C \u03b3 by PI 3-kinase-induced PH domain-mediated membrane targeting. EMBO J 1998; 17: 414\u2013422.","journal-title":"EMBO J"},{"key":"BFonc201210_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/364249a0","volume":"364","author":"W Kolch","year":"1993","unstructured":"Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H et al. Protein kinase C-\u03b1 activates RAF-1 by direct phosphorylation. Nature 1993; 364: 249\u2013252.","journal-title":"Nature"},{"key":"BFonc201210_CR21","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0021-9258(17)42250-2","volume":"269","author":"MP Carroll","year":"1994","unstructured":"Carroll MP, May WS . Protein kinase C-mediated serine phosphorylation directly activates Raf-1 in murine. J Biol Chem 1994; 269: 1249\u20131256.","journal-title":"J Biol Chem"},{"key":"BFonc201210_CR22","first-page":"2517","volume":"13","author":"AM Cacace","year":"1996","unstructured":"Cacace AM, Ueffing M, Philipp A, Han EK, Kolch W, Weinstein IB . PKC-\u025b functions as an oncogene by enhancing activation of the Raf kinase. Oncogene 1996; 13: 2517\u20132526.","journal-title":"Oncogene"},{"key":"BFonc201210_CR23","doi-asserted-by":"publisher","first-page":"33592","DOI":"10.1074\/jbc.271.52.33592","volume":"271","author":"Y Zou","year":"1996","unstructured":"Zou Y, Komuro I, Yamazaki T, Aikawa R, Kudoh S, Shiojima I et al. Protein kinase C, but not tyrosine kinases or Ras, plays a critical role in angiotensin II-induced activation of Raf-1 kinase and extracellular signal-regulated protein kinases in cardiac myocytes. J Biol Chem 1996; 271: 33592\u201333597.","journal-title":"J Biol Chem"},{"key":"BFonc201210_CR24","doi-asserted-by":"publisher","first-page":"23512","DOI":"10.1074\/jbc.271.38.23512","volume":"271","author":"Y Ueda","year":"1996","unstructured":"Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K, Ohno S . Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem 1996; 271: 23512\u201323519.","journal-title":"J Biol Chem"},{"key":"BFonc201210_CR25","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1128\/MCB.17.2.732","volume":"17","author":"H Cai","year":"1997","unstructured":"Cai H, Smola U, Wixler V, Eisenmann-Tappe I, Diaz-Meco MT, Moscat J et al. Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase. Mol Cell Biol 1997; 17: 732\u2013741.","journal-title":"Mol Cell Biol"},{"key":"BFonc201210_CR26","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1091\/mbc.9.4.749","volume":"9","author":"QS Ji","year":"1998","unstructured":"Ji QS, Ermini S, Baulida J, Sun FL, Carpenter G . Epidermal growth factor signaling and mitogenesis in Plcg1 null mouse embryonic fibroblasts. Mol Biol Cell 1998; 9: 749\u2013757.","journal-title":"Mol Biol Cell"},{"key":"BFonc201210_CR27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1083\/jcb.127.3.847","volume":"127","author":"P Chen","year":"1994","unstructured":"Chen P, Xie H, Sekar MC, Gupta K, Wells A . Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol 1994; 127: 847\u2013857.","journal-title":"J Cell Biol"},{"key":"BFonc201210_CR28","first-page":"5629","volume":"63","author":"SM Thomas","year":"2003","unstructured":"Thomas SM, Coppelli FM, Wells A, Gooding WE, Song J, Kassis J et al. Epidermal growth factor receptor-stimulated activation of phospholipase C-\u03b31 promotes invasion of head and neck squamous cell carcinoma. Cancer Res 2003; 63: 5629\u20135635.","journal-title":"Cancer Res"},{"key":"BFonc201210_CR29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1006\/bbrc.1996.0719","volume":"222","author":"MR Smith","year":"1996","unstructured":"Smith MR, Liu YL, Kim SR, Bae YS, Kim CG, Kwon KS et al. PLC-\u03b31 Src homology domain induces mitogenesis in quiescent NIH 3T3 fibroblasts. Biochem Biophys Res Commun 1996; 222: 186\u2013193.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc201210_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0014-5793(94)01453-8","volume":"358","author":"PS Huang","year":"1995","unstructured":"Huang PS, Davis L, Huber H, Goodhart PJ, Wegrzyn RE, Oliff A et al. An SH3 domain is required for the mitogenic activity of microinjected phospholipase C-\u03b31. FEBS Lett 1995; 358: 287\u2013292.","journal-title":"FEBS Lett"},{"key":"BFonc201210_CR31","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1128\/MCB.18.1.590","volume":"18","author":"Z Wang","year":"1998","unstructured":"Wang Z, Gluck S, Zhang L, Moran MF . Requirement for phospholipase C-\u03b31 enzymatic activity in growth factor-induced mitogenesis. Mol Cell Biol 1998; 18: 590\u2013597.","journal-title":"Mol Cell Biol"},{"key":"BFonc201210_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.bbrc.2010.05.103","volume":"397","author":"Z Xie","year":"2010","unstructured":"Xie Z, Chen Y, Liao EY, Jiang Y, Liu FY, Pennypacker SD . Phospholipase C-\u03b31 is required for the epidermal growth factor receptor-induced squamous cell carcinoma cell mitogenesis. Biochem Biophys Res Commun 2010; 397: 296\u2013300.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc201210_CR33","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.bbrc.2010.07.007","volume":"398","author":"Z Xie","year":"2010","unstructured":"Xie Z, Chen Y, Pennypacker SD, Zhou Z, Peng D . The SH3 domain, but not the catalytic domain, is required for phospholipase C-\u03b31 to mediate epidermal growth factor-induced mitogenesis. Biochem Biophys Res Commun 2010; 398: 719\u2013722.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc201210_CR34","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/415541a","volume":"415","author":"K Ye","year":"2002","unstructured":"Ye K, Aghdasi B, Luo HR, Moriarity JL, Wu FY, Hong JJ et al. Phospholipase C-\u03b31 is a physiological guanine nucleotide exchange factor for the nuclear GTPase PIKE. Nature 2002; 415: 541\u2013544.","journal-title":"Nature"},{"key":"BFonc201210_CR35","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0092-8674(00)00195-1","volume":"103","author":"K Ye","year":"2000","unstructured":"Ye K, Hurt KJ, Wu FY, Fang M, Luo HR, Hong JJ et al. PIKE: A Nuclear GTPase that Enhances PI3Kinase Activity and Is Regulated by Protein 4.1N. Cell 2000; 103: 919\u2013930.","journal-title":"Cell"},{"key":"BFonc201210_CR36","doi-asserted-by":"crossref","first-page":"32358","DOI":"10.1016\/S0021-9258(18)31643-0","volume":"269","author":"A Toker","year":"1994","unstructured":"Toker A, Meyer M, Reddy KK, Falck JR, Aneja R, Aneja S et al. Activation of protein kinase C family members by the novel polyphosphoinositides PtdIns-3,4-P2 and PtdIns-3,4,5-P3. J Biol Chem 1994; 269: 32358\u201332367.","journal-title":"J Biol Chem"},{"key":"BFonc201210_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1006\/excr.1999.4671","volume":"253","author":"G Carpenter","year":"1999","unstructured":"Carpenter G, Ji Q . Phospholipase C-\u03b3 as a signal-transducing element. Exp Cell Res 1999; 253: 15\u201324.","journal-title":"Exp Cell Res"},{"key":"BFonc201210_CR38","doi-asserted-by":"publisher","first-page":"31130","DOI":"10.1074\/jbc.272.49.31130","volume":"272","author":"G Zhou","year":"1997","unstructured":"Zhou G, Seibenhener ML, Wooten MW . Nucleolin is a protein kinase C-\u03b6 substrate. Connection between cell surface signaling and nucleus in PC12 cells. J Biol Chem 1997; 272: 31130\u201331137.","journal-title":"J Biol Chem"},{"key":"BFonc201210_CR39","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1242\/jcs.112.6.761","volume":"112","author":"H Ginisty","year":"1999","unstructured":"Ginisty H, Sicard H, Roger B, Bouvet P . Structure and function of nucleolin. J Cell Sci 1999; 112: 761\u2013772.","journal-title":"J Cell Sci"},{"key":"BFonc201210_CR40","first-page":"407","volume":"33","author":"R Tuteja","year":"1998","unstructured":"Tuteja R, Tuteja N . Nucleolin: a multifunctional major nucleolar phosphoprotein. Crit Rev Eukaryot Gene Expr 1998; 33: 407\u2013436.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"BFonc201210_CR41","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1096\/fasebj.13.14.1911","volume":"13","author":"M Srivastava","year":"1999","unstructured":"Srivastava M, Pollard HB . Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J 1999; 13: 1911\u20131922.","journal-title":"FASEB J"},{"key":"BFonc201210_CR42","doi-asserted-by":"publisher","first-page":"6993","DOI":"10.1073\/pnas.0400921101","volume":"101","author":"J-Y Ahn","year":"2004","unstructured":"Ahn J-Y, Hu Y, Kroll TG, Allard P, Ye K . PIKE-A is amplified in human cancers and prevents apoptosis by up-regulating Akt. Proc Natl Acad Sci USA 2004; 101: 6993\u20136998.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201210_CR43","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1038\/sj.onc.1210290","volume":"26","author":"X Liu","year":"2007","unstructured":"Liu X, Hu Y, Hao C, Rempel SA, Ye K . PIKE-A is a proto-oncogene promoting cell growth, transformation and invasion. Oncogene 2007; 26: 4918\u20134927.","journal-title":"Oncogene"},{"key":"BFonc201210_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0014-5793(96)01481-0","volume":"401","author":"Y Mizukami","year":"1997","unstructured":"Mizukami Y, Hirata T, Yoshida K . Nuclear translocation of PKC-\u03b6 during ischemia and its inhibition by wortmannin, an inhibitor of phosphatidylinositol 3-kinase. FEBS Lett 1997; 401: 247\u2013251.","journal-title":"FEBS Lett"},{"key":"BFonc201210_CR45","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1096\/fasebj.13.15.2299","volume":"13","author":"LM Neri","year":"1999","unstructured":"Neri LM, Martelli AM, Borgatti P, Colamussi ML, Marchisio M, Capitani S . Increase in nuclear phosphatidylinositol 3-kinase activity and phosphatidylinositol (3,4,5) trisphosphate synthesis precede PKC-\u03b6 translocation to the nucleus of NGF-treated PC12 cells. FASEB J 1999; 13: 2299\u20132310.","journal-title":"FASEB J"},{"key":"BFonc201210_CR46","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0014-5793(02)02401-8","volume":"514","author":"MC Calcerrada","year":"2002","unstructured":"Calcerrada MC, Miguel BG, Martin L, Catalan RE, Martinez AM . Involvement of phosphatidylinositol 3-kinase in nuclear translocation of protein kinase C-\u03b6 induced by C2-ceramide in rat hepatocytes. FEBS Lett 2002; 514: 361\u2013365.","journal-title":"FEBS Lett"},{"key":"BFonc201210_CR47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4161\/cib.4.3.14884","volume":"4","author":"MM Tajrishi","year":"2011","unstructured":"Tajrishi MM, Tuteja R, Tuteja N . Nucleolin: The most abundant multifunctional phosphoprotein of nucleolus. Commun Integr Biol 2011; 4: 267\u2013275.","journal-title":"Commun Integr Biol"},{"key":"BFonc201210_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1042\/BC20080054","volume":"101","author":"S Storck","year":"2009","unstructured":"Storck S, Thiry M, Bouvet P . Conditional knockout of nucleolin in DT40 cells reveals the functional redundancy of its RNA-binding domains. Biol Cell 2009; 101: 153\u2013167.","journal-title":"Biol Cell"},{"key":"BFonc201210_CR49","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/jcp.1041340208","volume":"134","author":"S Pillai","year":"1988","unstructured":"Pillai S, Bikle DD, Hincenbergs M, Elias PM . Biochemical and morphological characterization of growth and differentiation of normal human neonatal keratinocytes in a serum-free medium. J Cell Physiol 1988; 134: 229\u2013237.","journal-title":"J Cell Physiol"},{"key":"BFonc201210_CR50","doi-asserted-by":"publisher","first-page":"8695","DOI":"10.1074\/jbc.M609135200","volume":"282","author":"Z Xie","year":"2007","unstructured":"Xie Z, Bikle DD . The recruitment of phosphatidylinositol 3-kinase to the E-cadherin-catenin complex at the plasma membrane is required for calcium-induced phospholipase C-\u03b31 activation and human keratinocyte differentiation. J Biol Chem 2007; 282: 8695\u20138703.","journal-title":"J Biol Chem"},{"key":"BFonc201210_CR51","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1091\/mbc.e08-07-0756","volume":"20","author":"Z Xie","year":"2009","unstructured":"Xie Z, Chang SM, Pennypacker SD, Liao EY, Bikle DD . Phosphatidylinositol-4-phosphate 5-kinase 1\u03b1 mediates extracellular calcium-induced keratinocyte differentiation. Mol Biol Cell 2009; 20: 1695\u20131704.","journal-title":"Mol Biol Cell"},{"key":"BFonc201210_CR52","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1091\/mbc.e05-02-0109","volume":"16","author":"Z Xie","year":"2005","unstructured":"Xie Z, Singleton PA, Bourguignon LY, Bikle DD . Calcium-induced human keratinocyte differentiation requires src- and fyn-mediated phosphatidylinositol 3-kinase-dependent activation of phospholipase C-\u03b31. Mol Biol Cell 2005; 16: 3236\u20133246.","journal-title":"Mol Biol Cell"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc201210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201210","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:09:15Z","timestamp":1647886155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc201210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,20]]},"references-count":52,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2012,12,6]]}},"alternative-id":["BFonc201210"],"URL":"https:\/\/doi.org\/10.1038\/onc.2012.10","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,20]]},"assertion":[{"value":"26 August 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors disclose no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}